Study in Patients With Moderated to Severe Rheumatoid Arthritis Who Have Failed to Combination Therapy of Conventional Disease-modifying Antirheumatic Drugs (cDMARDs) to cDMARD Plus ANti-TNF Versus cDMARDs in Real World
Clinical trial NCT03264703 · COMPLETED
Trial details
- NCT number
- NCT03264703
- Sponsor
- Eisai Korea Inc.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2017-09-11
- Primary completion
- 2019-07-17
- Enrollment
- 212
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.